uniQure (QURE) Assets Average (2017 - 2026)
uniQure (QURE) posted quarterly Assets Average of $881.9 million for Q2 2026, up 48.18% year-over-year from $595.1 million in Q2 2025, and up 9.99% quarter-over-quarter from $801.8 million in Q1 2026.
uniQure (QURE) Assets Average (2017 - 2026) Analysis & Trends
uniQure's Assets Average history runs 10 years deep, the most recent figure standing at $881.9 million for Q2 2026.
- In Q2 2026, Assets Average rose 48.18% year-over-year to $881.9 million; the TTM figure through Jun 2026 stood at $881.9 million (up 48.18% YoY), while the FY2025 annual figure was $690.7 million, changed 0.49% from the prior year.
- Assets Average for Q2 2026 stood at $881.9 million, up from $801.8 million in the prior quarter.
- The five-year high for Assets Average was $907.2 million in Q3 2023, with the low at $581.0 million in Q1 2025.
- The 5-year median for Assets Average is $743.5 million (2024), against an average of $742.3 million.
- The sharpest annual moves came in 2022 and 2024: Assets Average soared 122.41% in 2022, then retreated 29.41% in 2024.
- uniQure's Assets Average stood at $671.6 million in 2022, then gained by 26.8% to $851.6 million in 2023, then slipped by 29.41% to $601.2 million in 2024, then jumped by 42.5% to $856.6 million in 2025, then grew by 2.95% to $881.9 million in 2026.
- Business Quant data shows QURE's Assets Average at $881.9 million in Q2 2026, $801.8 million in Q1 2026, and $856.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn | 881.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 881.90 Mn |
| Mar 31, 2026 | 801.81 Mn |
| Dec 31, 2025 | 856.65 Mn |
| Sep 30, 2025 | 736.64 Mn |
| Jun 30, 2025 | 595.15 Mn |
| Mar 31, 2025 | 580.97 Mn |
| Dec 31, 2024 | 601.17 Mn |
| Sep 30, 2024 | 688.33 Mn |
| Jun 30, 2024 | 750.45 Mn |
| Mar 31, 2024 | 800.87 Mn |
| Dec 31, 2023 | 851.62 Mn |
| Sep 30, 2023 | 907.16 Mn |
| Jun 30, 2023 | 786.89 Mn |
| Mar 31, 2023 | 667.98 Mn |
| Dec 31, 2022 | 671.60 Mn |
| Sep 30, 2022 | 669.72 Mn |
| Jun 30, 2022 | 729.18 Mn |
| Mar 31, 2022 | 783.17 Mn |
| Dec 31, 2021 | 791.90 Mn |
| Sep 30, 2021 | 779.44 Mn |